Arbutus Biopharma Corporation/ CA03879J1003 /
2024-06-10 10:00:00 PM | Chg. -0.0600 | Volume | Bid1:56:43 AM | Ask1:56:43 AM | High | Low |
---|---|---|---|---|---|---|
3.1400USD | -1.88% | 1.18 mill. Turnover: 3.39 mill. |
3.1600Bid Size: 1,000 | 3.2000Ask Size: 800 | 3.2100 | 3.1100 |
GlobeNewswire
06-06
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statisti...
GlobeNewswire
06-06
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Le...
GlobeNewswire
06-05
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity f...
GlobeNewswire
05-02
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-02
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December ...
GlobeNewswire
04-18
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire
04-04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
03-20
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
GlobeNewswire
02-29
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire
02-15
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
GlobeNewswire
2023-11-15
Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire
2023-11-09
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Coll...
GlobeNewswire
2023-11-09
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining ...
GlobeNewswire
2023-11-07
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-11-06
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immuno...
GlobeNewswire
2023-10-24
Arbutus to Report Third Quarter 2023 Financial Results and Provide Corporate Update
GlobeNewswire
2023-10-18
Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Virtual Conference
GlobeNewswire
2023-10-11
Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023